Anticoagulation regimens of patients without further APS related events
| Treatment | No of patients (n=38) |
|---|---|
| *Patient 1: End stage renal disease, receiving haemodialysis, waiting for renal transplantation. Patient 2: Aspirin for six years followed by no treatment for four years; †End stage renal disease, receiving haemodialysis, waiting for renal transplantation; ‡Stopped heparin six weeks post partum. | |
| Warfarin (INR not reported) | 10 |
| Warfarin (INR 2–3) | 7 |
| Warfarin (INR 2.5–3.5) | 4 |
| Warfarin (INR 3–4) | 10 |
| Warfarin + Clopidogrel | 1 |
| Fluindione | 1 |
| Acenocoumarol | 1 |
| Aspirin* | 2 |
| No treatment† | 1 |
| Heparin/aspirin‡ | 1 |